Not applicableStudy completedNCT04328662What this trial is testingNinlaro in Real World Clinical Practice in ChinaWho this might be right forMultiple MyelomaNeoplasms, Plasma Cell Takeda 482
Not applicableEnrolling By InvitationNCT05212103What this trial is testingPET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9Who this might be right forAcute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer Turku University Hospital 30
Early research (Phase 1)Study completedNCT00410982What this trial is testingGemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid MalignanciesWho this might be right forLeukemiaLymphomaMyeloma M.D. Anderson Cancer Center 145
Early research (Phase 1)Study completedNCT01713582What this trial is testingA Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)Who this might be right forAcute Myeloid LeukemiaDiffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia+1 more Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 141
Large-scale testing (Phase 3)Ended earlyNCT00500240What this trial is testingEffect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)Who this might be right forLeukemiaLymphoma M.D. Anderson Cancer Center 52
Not applicableLooking for participantsNCT06710418What this trial is testingEvaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/LeukemiaWho this might be right forAcute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more University of Washington 50
Early research (Phase 1)Study completedNCT01410513What this trial is testingStudy Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic LeukemiaWho this might be right forIndolent Non-Hodgkin LymphomaMantle Cell LymphomaChronic Lymphocytic Leukemia Sanofi 37
Not applicableEnded earlyNCT00578292What this trial is testingAllogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLOWho this might be right forThalassemia Baylor College of Medicine 10
Large-scale testing (Phase 3)Looking for participantsNCT06756152What this trial is testingPreventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with HemoblastosisWho this might be right forBiphenotypic Acute LeukemiaAcute Lymphoblastic LeukemiaMyeloblastic Leukemia+3 more Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50
Early research (Phase 1)Temporarily pausedNCT07388563What this trial is testingAzacitidine and Abatacept in Relapsed or Refractory T-Cell LymphomaWho this might be right forLymphoma, T Cell, PeripheralT-cell LymphomaAngioimmunoblastic T-cell Lymphoma+3 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00047021What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Case Comprehensive Cancer Center 3
Early research (Phase 1)WithdrawnNCT02640833What this trial is testingDuvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K InhibitorWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaNon-Hodgkin Lymphoma AbbVie
Early research (Phase 1)Study completedNCT02900716What this trial is testingSafety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell LymphomasWho this might be right forChronic Lymphocytic LeukemiaB-Cell Lymphoma Zhejiang DTRM Biopharma 48
Early research (Phase 1)Study completedNCT03892044What this trial is testingDuvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular LymphomaWho this might be right forChronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+5 more David Bond, MD 7
Testing effectiveness (Phase 2)Ended earlyNCT01685021What this trial is testingStudy of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL)Who this might be right forAcute Lymphoblastic Leukemia MorphoSys AG 22
Early research (Phase 1)Study completedNCT02594384What this trial is testingA Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic OrphAI Therapeutics 62
Large-scale testing (Phase 3)Looking for participantsNCT07297329What this trial is testingEvaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantWho this might be right forMultiple Myeloma (MM) Sinocelltech Ltd. 292
Early research (Phase 1)Ended earlyNCT01644253What this trial is testingPhase 1b Safety and Efficacy Study of TRU-016Who this might be right forChronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma Aptevo Therapeutics 87
Testing effectiveness (Phase 2)Study completedNCT00066092What this trial is testingPegfilgrastim PBPC Mobilization StudyWho this might be right forLymphomaHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more Amgen 41
Early research (Phase 1)Study completedNCT00002946What this trial is testingPenclomedine in Treating Patients With Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 30